D.A. Davidson & Co’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

D.A. Davidson & Co’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-345	Closed	–	–	2287
2017 Q2	$0	Hold	345	–	–	﹤0.01%	2481
2017 Q1	$0	Hold	345	–	–	﹤0.01%	2567
2016 Q4	$0	Buy	345 +40	+13%	+$27	﹤0.01%	2554
2016 Q3	$0	Hold	305	–	–	﹤0.01%	2532
2016 Q2	$0	Hold	305	–	–	﹤0.01%	2437
2016 Q1	$0	Hold	305	–	–	﹤0.01%	2391
2015 Q4	$0	Hold	305	–	–	﹤0.01%	2323
2015 Q3	$0	Hold	305	–	–	﹤0.01%	2332
2015 Q2	$0	Hold	305	–	–	﹤0.01%	2333
2015 Q1	$0	Hold	305	–	–	﹤0.01%	2205
2014 Q4	$0	Buy	+305	New	+$331	﹤0.01%	2217

Other funds holding BTX.WS

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

D.A. Davidson & Co's BTX.WS Position: Q3 2017 in Review

D.A. Davidson & Co sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2017, closing a stake of 345 shares.

D.A. Davidson & Co first reported a position in BTX.WS in Q4 2014 and held it in 11 quarters. The position peaked at $0 in Q2 2017. 33 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2017.

D.A. Davidson & Co reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2017 after selling out during the quarter.
D.A. Davidson & Co sold 345 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2017.
D.A. Davidson & Co first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 11 quarters.
D.A. Davidson & Co's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q2 2017.
33 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.